blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3434690

EP3434690 - ANTIBODY THAT BINDS TO ENVELOPE GLYCOPROTEIN OF SEVERE FEVER WITH THROMBOCYTOPENIA SYNDROME VIRUS, AND USE FOR SAME [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  25.08.2023
Database last updated on 03.10.2024
FormerExamination is in progress
Status updated on  07.10.2022
FormerRequest for examination was made
Status updated on  30.12.2018
FormerThe international publication has been made
Status updated on  30.09.2017
Most recent event   Tooltip25.08.2023Application deemed to be withdrawnpublished on 27.09.2023  [2023/39]
Applicant(s)For all designated states
Seoul National University R&DB Foundation
1 Gwanak-ro
Gwanak-gu
Seoul 08826 / KR
For all designated states
Institut Pasteur Korea
16 Daewangpangyo-ro 712beon-gil
Bundang-gu
Seongnam-si, Gyeonggi 13488 / KR
[2019/05]
Inventor(s)01 / CHUNG, Junho
T-1801
170 Seohyeon-ro
Bundang-gu
Seongnam-si Gyeonggi-do 13590 / KR
02 / KIM, Ki-Hyun
A-1003
32 Gukjegeumyung-ro 7-gil
Yeongdeungpo-gu
Seoul 07341 / KR
03 / KIM, Hyori
310-303
435 Olympic-ro
Songpa-gu
Seoul 05507 / KR
04 / OH, Myoung-don
101 Daehak-ro
Jongno-gu
Seoul 03080 / KR
05 / PARK, Wan Beom
101 Daehak-ro
Jongno-gu
Seoul 03080 / KR
06 / KIM, Seungtaek
201-504, 847, Bugaksan-ro
Seongbuk-gu
Seoul 02818 / KR
07 / KIM, Jinhee
110-103, 190, Bundang-ro
Bundang-gu, Seongnam-si
Gyeonggo-do 13581 / KR
08 / MIN, Ji-Young
9717 Singleton Dr.
Bethesda, MD 20817 / US
09 / KO, Meehyun
632, 767, Sinsu-ro, Suji-gu
Yongin-si Gyeonggi-do 16827 / KR
 [2019/35]
Former [2019/05]01 / CHUNG, Junho
T-1801
170 Seohyeon-ro
Bundang-gu
Seongnam-si Gyeonggi-do 13590 / KR
02 / KIM, Ki-Hyun
A-1003
32 Gukjegeumyung-ro 7-gil
Yeongdeungpo-gu
Seoul 07341 / KR
03 / KIM, Hyori
310-303
435 Olympic-ro
Songpa-gu
Seoul 05507 / KR
04 / OH, Myoung-don
101 Daehak-ro
Jongno-gu
Seoul 03080 / KR
05 / PARK, Wan Beom
101 Daehak-ro
Jongno-gu
Seoul 03080 / KR
06 / KIM, Seungtaek
201-504, 847, Bugaksan-ro
Seongbuk-gu
Seoul 02818 / KR
07 / KIM, Jinhee
110-103, 190, Bundang-ro
Bundang-gu, Seongnam-si
Gyeonggo-do 13581 / KR
Representative(s)Graf von Stosch Patentanwaltsgesellschaft mbH
Prinzregentenstraße 22
80538 München / DE
[2019/05]
Application number, filing date17770648.823.03.2017
[2019/05]
WO2017KR03156
Priority number, dateKR2016003472723.03.2016         Original published format: KR 20160034727
[2019/05]
Filing languageKO
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2017164678
Date:28.09.2017
Language:KO
[2017/39]
Type: A2 Application without search report 
No.:EP3434690
Date:30.01.2019
Language:EN
[2019/05]
Search report(s)International search report - published on:KR07.09.2018
(Supplementary) European search report - dispatched on:EP28.02.2020
ClassificationIPC:C07K16/10, C07K14/175, C07K14/005, G01N33/543, G01N33/569, G01N35/00, A61K39/42
[2019/46]
CPC:
A61K39/42 (EP,US); C07K16/10 (KR); A61K39/395 (KR);
A61P31/14 (EP,KR,US); C07K14/005 (KR,US); C07K14/175 (EP,US);
C07K16/1003 (EP,US); C12N15/62 (EP,US); G01N33/54326 (KR);
G01N33/56983 (KR,US); G01N35/00029 (US); G01N35/0098 (KR);
C07K2317/565 (US); C07K2317/622 (EP,US); C07K2317/76 (EP,US);
C12N2760/12211 (KR) (-)
Former IPC [2019/05]C07K16/10, C07K14/005, G01N33/543, G01N33/569, G01N35/00
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2019/05]
TitleGerman:AN HÜLLGLYKOPROTEIN VON SCHWEREM-FIEBER-MIT-THROMBOZYTOPENIE-SYNDROM-VIRUS BINDENDER ANTIKÖRPER SOWIE VERWENDUNG DAFÜR[2019/05]
English:ANTIBODY THAT BINDS TO ENVELOPE GLYCOPROTEIN OF SEVERE FEVER WITH THROMBOCYTOPENIA SYNDROME VIRUS, AND USE FOR SAME[2019/05]
French:ANTICORPS QUI SE LIE À LA PROTÉINE D'ENVELOPPE DU VIRUS DU SYNDROME DE FIÈVRE SÉVÈRE AVEC THROMBOCYTOPÉNIE, ET SON UTILISATION[2019/05]
Entry into regional phase07.09.2018Translation filed 
07.09.2018National basic fee paid 
07.09.2018Search fee paid 
07.09.2018Designation fee(s) paid 
07.09.2018Examination fee paid 
Examination proceduredeletedDate on which the examining division has become responsible
07.09.2018Examination requested  [2019/05]
17.09.2020Amendment by applicant (claims and/or description)
11.10.2022Despatch of a communication from the examining division (Time limit: M06)
22.04.2023Application deemed to be withdrawn, date of legal effect  [2023/39]
19.05.2023Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2023/39]
Fees paidRenewal fee
06.03.2019Renewal fee patent year 03
31.03.2020Renewal fee patent year 04
25.03.2021Renewal fee patent year 05
30.03.2022Renewal fee patent year 06
Penalty fee
Additional fee for renewal fee
31.03.202307   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]WO02051870  (GRAD CAROLE [CA], et al);
 [A]WO03064606  (MEDAREX INC [US], et al);
 [A]WO2004006955  (FOOTE JEFFERSON [US]);
 [A]WO2006089231  (MEDAREX INC [US], et al);
 [A]WO2010045388  (DYAX CORP [US], et al);
 [A]WO2010059543  (MERCK SHARP & DOHME [US], et al);
 [A]WO2010061991  (KOREA RES INST OF BIOSCIENCE [KR], et al);
 [A]WO2010107752  (AMGEN INC [US], et al);
 [A]WO2010141249  (MERCK SHARP & DOHME [US], et al);
 [A]US2011091960  (SIEGEL DONALD L [US]);
 [A]WO2011071783  (AMGEN INC [US], et al);
 [A]WO2012048340  (HARVARD COLLEGE [US], et al);
 [A]WO2012076066  (BIOINVENT INT AB [SE], et al);
 [A]WO2012098089  (BAYER PHARMA AG [DE], et al);
 [A]WO2012170438  (AMGEN INC [US], et al);
 [A]WO2013063095  (ABBVIE INC [US], et al);
 [A]WO2013092998  (INNATE PHARMA [FR], et al);
International search[A]CN102942629  (JIANGSU PROVINCIAL CT FOR DISEASE PREVENTION AND CONTROL);
 [A]WO2015053455  (SNU R&DB FOUNDATION [KR]);
by applicantWO2015053455
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.